Ethiopia Launched National Strategy to Combat Substandard and Falsified Medical Products (2026–2030)

Pharmacovigilance Due Diligence in Drug Development: A Practical Playbook for Risk Identification, Compliance Assessment, and Strategic Decision Making

La AEMPS informa de la detección en el mercado europeo de unidades falsificadas de la prueba de autodiagnóstico COVID-19 and Influenza A+B Antigen Combo Rapid Test

OPS y ANMAT avanzan en la conformación de una red federal de farmacovigilancia en Argentina

Veterinary Drug Residues in Food Chains: Sources, Exposure Pathways, Health Impacts, Mitigation, and Safety Assurance

Research and practice on key drug safety monitoring under the normalization of centralized procurement: A case study of 13 selected drugs in a Province

A real-world pharmacovigilance study of FDA adverse event reporting system events for cefazolin

Guillain–Barré syndrome associated with immune checkpoint inhibitors exposure: a pharmacovigilance study

Drug toxicity deaths associated with opioid agonist treatment: An analysis of methadone and buprenorphine-related fatalities in Victoria, Australia

Hospitalization linked to antiepileptics, sedative-hypnotics and anti-Parkinsonian drug poisoning, adverse effects, and underdosing in Australia: An ecological study

ISP incorporará la terminología MedDRA al Sistema de Vigilancia Integrada (SVI) para el reporte de eventos adversos

Safety of Drugs Used in Difficult-to-Treat Epileptic Syndromes: A Disproportionality Analysis Using the Eudravigilance Database

Pattern, Severity, and Preventability of Adverse Drug Reactions in a Tertiary-Care Hospital: Insights from Central India

Nuevo método de tecnovigilancia para dispositivos de estimulación eléctrica transcorneal

Leveraging Large Language Models for Adverse Drug Event Detection: A Comparative Study of Token and Span-Based Named Entity Recognition

Adverse drug event signal detection and risk factor analysis of blinatumomab in ten years of post-marketing use

Chinese Herbal Medicine in Pediatric Oncology: Effects on Survival and Toxicity – A Meta-analysis

Nonfatal Drug Overdose in a National Sample of Adolescents by Intent and Substance, Medicaid 2016-2020

Trial-Based Costs for Interventions to Improve HPV Vaccine Uptake

High-Risk Penicillin Reaction Flags in the Medical Record

Contraceptive Tied to Higher Brain Tumor Risk in Women

A 24-year pharmacovigilance study on sex differences in adverse drug reactions to antidepressant drugs

Medical Product Alert N°7/2025: Falsified IBRANCE (palbociclib)

Leveraging the Lanham Act for anti-counterfeiting: A case study of Gilead Sciences' successful civil-to-criminal enforcement strategy in the US pharmaceutical market

Blockchain and Artificial Intelligence in Pharmaceutical Supply Chain Traceability: A Systematic Review

Evaluation of performance measures in predictive artificial intelligence models to support medical decisions: overview and guidance

The impact of artificial intelligence-driven decision support on uncertain antimicrobial prescribing: a randomised, multimethod study

WHO and the European Commission expand partnership to combat antimicrobial resistance

Statement of the WHO Global Advisory Committee on Vaccine Safety (GACVS) on vaccines and autism

Precision pharmacovigilance integrates genomics and real world evidence to overcome drug safety barriers

Diseases are not treated with words, but with medicines. Setting up galenic laboratories in Africa

Performance of the Self‐Controlled Case Series With Active Comparators for Drug Safety Signal Detection Using the Clinical Practice Research Datalink (CPRD)

A Patient Needs a Drug. They Have Their Own Ideas. What Now?